| Serial Number | 99375298 |
| Word Mark | NANOPRISM |
| Filing Date | Thursday, September 4, 2025 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, February 2, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Reagents for scientific or research use, namely, assay reagents for bioluminescence and resonance energy transfer; small molecule reagents for scientific or research use, namely, substrates for bioluminescent proteins; small molecule reagents for scientific or research use, namely, detectably labeled ligands for resonance energy transfer |
| Pseudo Mark | NANO PRISM |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 4, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Promega Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Madison, WI 53711-5399 US |
| Event Date | Event Description |
| Thursday, September 4, 2025 | NEW APPLICATION ENTERED |
| Thursday, September 4, 2025 | APPLICATION FILING RECEIPT MAILED |
| Sunday, January 25, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 26, 2026 | ASSIGNED TO EXAMINER |
| Monday, February 2, 2026 | NON-FINAL ACTION WRITTEN |
| Monday, February 2, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, February 2, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |